Personalis Net Income 2018-2024 | PSNL
Personalis net income from 2018 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Personalis Annual Net Income (Millions of US $) |
2023 |
$-108 |
2022 |
$-113 |
2021 |
$-65 |
2020 |
$-41 |
2019 |
$-25 |
2018 |
$-20 |
2017 |
$-24 |
Personalis Quarterly Net Income (Millions of US $) |
2024-06-30 |
$-13 |
2024-03-31 |
$-13 |
2023-12-31 |
$-27 |
2023-09-30 |
$-29 |
2023-06-30 |
$-24 |
2023-03-31 |
$-29 |
2022-12-31 |
$-31 |
2022-09-30 |
$-26 |
2022-06-30 |
$-28 |
2022-03-31 |
$-28 |
2021-12-31 |
$-20 |
2021-09-30 |
$-18 |
2021-06-30 |
$-15 |
2021-03-31 |
$-12 |
2020-12-31 |
$-13 |
2020-09-30 |
$-10 |
2020-06-30 |
$-9 |
2020-03-31 |
$-9 |
2019-12-31 |
$-7 |
2019-09-30 |
$-7 |
2019-06-30 |
$-6 |
2019-03-31 |
$-6 |
2018-12-31 |
|
2018-09-30 |
$-4 |
2018-06-30 |
$-7 |
2017-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.270B |
$0.073B |
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|